Aoxin Q & M Dental Group (SGX:1D4) Other Current Receivables: S$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:1D4 Aoxin Q & M Dental Group Ltd SGX:1D4
59 GF Score
Price S$0.21
GF Value S$0.03
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Aoxin Q & M Dental Group Other Current Receivables?

Aoxin Q & M Dental Group SGX:1D4 -2.33% 59 Other Current Receivables is S$0.00 Mil as of Jun. 2026. GuruFocus rates SGX:1D4 with a GF Score™ of 59/100 and a GF Value™ of S$0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Aoxin Q & M Dental Group's Other Current Receivables for the quarter that ended in Jun. 2026 was S$0.00 Mil.

Aoxin Q & M Dental Group's annual Other Current Receivables increased from Dec. 2023 (S$1.34 Mil) to Dec. 2024 (S$1.42 Mil) but then declined from Dec. 2024 (S$1.42 Mil) to Dec. 2025 (S$1.20 Mil).

Aoxin Q & M Dental Group Other Current Receivables Related Terms

Aoxin Q & M Dental Group Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Aoxin Q & M Dental Group's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxin Q & M Dental Group Other Current Receivables Chart

Aoxin Q & M Dental Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.30 1.41 1.34 1.42 1.20

Aoxin Q & M Dental Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.42 0.00 1.20 0.00
SGX:1D4
59GF Score
Aoxin Q & M Dental Group Ltd SGX:1D4
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aoxin Q & M Dental Group Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of S$0.00 Mil mean?
Aoxin Q & M Dental Group (SGX:1D4) has a Other Current Receivables of S$0.00 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Aoxin Q & M Dental Group and its competitors.
Is Aoxin Q & M Dental Group's Other Current Receivables too high?
Aoxin Q & M Dental Group's current Other Current Receivables is S$0.00 Mil. Overall, Aoxin Q & M Dental Group has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aoxin Q & M Dental Group's Other Current Receivables compare to HCA and THC?
Aoxin Q & M Dental Group's Other Current Receivables of S$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Aoxin Q & M Dental Group and its competitors. Aoxin Q & M Dental Group's current Other Current Receivables is S$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxin Q & M Dental Group stock overvalued right now?
Based on GuruFocus' analysis, Aoxin Q & M Dental Group (SGX:1D4) is currently considered Significantly Overvalued. The stock's GF Value™ is S$0.03, compared to a current price of S$0.21 — trading 600% above its estimated fair value. The current Other Current Receivables is S$0.00 Mil. Aoxin Q & M Dental Group's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Aoxin Q & M Dental Group (SGX:1D4), the current Other Current Receivables is S$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aoxin Q & M Dental Group (SGX:1D4) Overvalued in 2026?

Based on GuruFocus' analysis, Aoxin Q & M Dental Group stock appears to be overvalued. The current stock price of S$0.21 is trading 600% above its estimated GF Value™ of S$0.03. GuruFocus considers Aoxin Q & M Dental Group to be Significantly Overvalued.

Key valuation signals for SGX:1D4:

  • Other Current Receivables: S$0.00 Mil
  • GF Value™: S$0.03 vs. price of S$0.21 (600% above fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the SGX:1D4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aoxin Q & M Dental Group Business Description

Address 9 Raffles Place, No. 26-01, Republic Plaza, Singapore, SGP, 048619
Aoxin Q & M Dental Group Ltd, along with its subsidiaries, offers private dental services, dental equipment, and supplies. The various dental care services offered by the Group include Stomatology and general dentistry, Endodontics, Orthodontics, Periodontics, Dental implantology, and many more. Its dental equipment and supplies portfolio includes dental chairs, ultrasound scanners, dental instruments, materials, and consumables for dental hospitals, clinics, distributors, and laboratories. The Group's reportable operating segments are: Primary healthcare, which generates the maximum revenue, Distribution of dental equipment and supplies, and Laboratory services. Geographically, it generates maximum revenue from the People's Republic of China (PRC) and the rest from Singapore.
59GF Score

Get the complete analysis for SGX:1D4

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.21
Price
S$0.03
GF Value